USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, but more research is needed to provide a clearer picture, researchers ...

What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).

The Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, Wegovy and Ozempic.

“We're not proposing that semaglutide causes erectile dysfunction or that it causes low testosterone, but there's an association between the two,” says Dr. Sonstein. So, what’s going on here?

The diabetes and weight loss drug tirzepatide — sold as Mounjaro and Zepbound, respectively — significantly improved heart failure symptoms and related physical limitations in a new study. [1] ...

Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to ...

Did you know there's a relationship between high blood pressure and erectile dysfunction? Both conditions are part of a bigger set of health issues.

Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.

A new large-scale study found that the diabetes medication Mounjaro (tirzepatide) outperformed Ozempic for weight loss. Mounjaro may be more effective because it incorporates a gastrointestinal ...